Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: Evidence from an 18 months longitudinal study

Journal of Psychopharmacology

Volumn 20, Issue 2, 2006, Pages 236-244

  Daumann, Jörg ^a   Till, Bianca ^b   Fischermann, Thomas ^a   Rezk, Markus ^b   Gouzoulis Mayfrank, Euphrosyne ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Auditory evoked potentials; Ecstasy; MDMA; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PSYCHEDELIC AGENT; SEROTONIN RECEPTOR AFFECTING AGENT; STREET DRUG;

ADULT; ARTICLE; AUDITORY STIMULATION; BRAIN; BRAIN CORTEX; CANNABIS ADDICTION; CELL DEATH; DICHOTIC LISTENING; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG INTERACTION; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; FOLLOW UP; HEARING; HEMISPHERIC DOMINANCE; HUMAN; MALE; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SOUND DETECTION;

ACOUSTIC STIMULATION; ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; CELL DEATH; CEREBRAL CORTEX; DICHOTIC LISTENING TESTS; DOMINANCE, CEREBRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; HALLUCINOGENS; HUMANS; LOUDNESS PERCEPTION; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; SEROTONIN AGENTS; SOUND SPECTROGRAPHY; STREET DRUGS;

EID: 33746793885     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106059733     Document Type: Article

References (52)

1. Azmitia E C, Gannon P J (1986) The primate serotonergic system: a review of human and animal studies and a report of macaca fascicularis. Adv Neurology 43: 407-468
2. Barrat E S, Pritchard W S, Faulk D M, Brandt M E (1987) The relationship between impulsiveness subtraits, trait anxiety, and visual N100 augmenting/reducing: A topographic analysis. Person Individ Diff 8: 43-51
3. Battaglia G, Yeh S Y, ÓHearn E, Molliver M E, Kuhar M J, De Souza E B (1987) 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H] paroxetine-labelled serotonin uptake sites. J Pharmacol Exp Ther 242: 911-916
4. Bhattachary S, Powell J H (2001) Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 31: 647-658
5. Bolla K I, McCann U D, Ricaurte G A (1998) Memory impairment in abstinent MDMA ('Ecstasy') users. Neurology 51: 1532-1537
6. Brown J, Kranzler H R, Del Boca F K (1992) Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity. Br J Addict 87: 1013-1024
7. Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M (2004) A voxel-based PET investigation of the long-term effects of 'Ecstasy' consumption on brain serotonin transporters. Am J Psychiatry 161: 1181-1189
8. Buchsbaum M S, Silverman J (1968) Stimulus intensity control and cortical evoked response. Psychosom Med 30: 12-22
9. Campbell M J, Lewis D A, Foote S L, Morrison J H (1987) Distribution of choline acetyltransferase-, serotonin-, dopamine-b-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex. J Comp Neurol 261: 209-220
10. Carrillo-de-la-Pena M T (1992) ERP augmenting/reducing and sensation seeking: a critical review. Int J Psychophysiol 12: 211-220
11. Carrillo-de-la-Pena M T (1998) Effect of stimulus intensity and order of stimulus presentation on auditory evoked potentials (AEPs). An analysis of the consistency of augmenting/reducing (A/R) Phenomenon. Int J Psychophysiol 20 1-2: 214
12. Croft R J, Klugman A, Baldeweg T, Gruzelier J H (2001) Electrophysiological evidence of serotonergic impairment in long-term MDMA ('ecstasy') users. Am J Psychiatry 158: 1687-1692
13. Curran V H (2000) Is MDMA (Ecstasy) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42: 34-41
14. Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E (2004) Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol Psychiatry 56: 349-355
15. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G A (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). J Neurosci 15: 5476-5485
16. Gouzoulis-Mayfrank E, Timm B, Rezk M, Hensen G, Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progr Neuropsychopharmacol Biol Psychiatry 27: 819-827
17. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H J, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68: 719-725
18. Green A R, Mechan A O, Elliott M, ÓShea E, Colado M I (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Pharmacol Rev 55: 463-508
19. Harrison E R, Haaga J, Richards T (1993) Self-reported drug use data: What do they reveal? Am J Drug Alcohol Abuse 19: 423-441
20. Hatzidimitriou G, McCann U D, Ricaurte G A (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4- methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19: 5096-5107
21. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33: 173-187
22. Hegerl U, Juckel G (2000) Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 1: 112-118
23. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 62: 93-100
24. Hegerl U, Gallinat J, Mrowinski D (1994) Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17: 1-13
25. Hegerl U, Gallinat J, Mrowinski D (1995a) Sensory cortical processing and the biological basis of personality. Biol Psychiatry 37: 467-472
26. Hegerl U, Juckel G, Rao M L, Müller-Oerlinghausen B (1991) Blood serotonin and auditory evoked potentials under fluvoxamine challenge and phototherapy. In Cassano G B, Akiskal H S (eds), Serotonin-related Psychiatric Syndromes: Clinical and Therapeutic Links. Royal Soc Med, London
27. Hegerl U, Lipperheide K, Juckel G, Schmidt L G, Rommelspacher H (1995b) Antisocial tendencies and cortical sensory evoked responses in alcoholism. Alcohol Clin Exp Res 19: 31-36
28. Juckel G, Schmidt L G, Rommelspacher H, Hegerl U (1995) The tridimensional personality questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiatry 37: 311-317
29. Kita T, Wagner G C, Nakashima T (2003) Current research on methamphetamine- induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92: 178-195
30. Lewis D A, Campbell M J, Foote S L, Goldstein M, Morrison J H (1987) The distribution of tyrosine hydroxylase-immunoreactive fibres in primate neocortex is widespread but regionally specific. J Neurosci 7: 279-290
31. Lukas J H (1987) Human augmenting-reducing and sensation seeking. Psychophysiol 19: 333-334
32. McCann U D, Szabo Z, Scheffel U, Dannals R F, Ricaurte G A (1998) Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings. Lancet 352: 1433-1437
33. McCann U D, Szabo Z, Seckin E, Rosenblatt P, Mathews W B, Ravert H T, Dannals R F, Ricaurte G A (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [(11)C]McN5652 and [(11)C]DASB. Neuropsychopharmacology 30: 1741-1740
34. Morgan M J (1999) Memory deficits associated with recreational use of 'ecstasy' (MDMA). Psychopharmacology 141: 30-36
35. Morrison J H, Foote S L (1986) Noradrenergic and serotonergic innervation of cortical, thalamic and tectal visual structures in old and new world monkeys. J Comp Neurol 243: 117-138
36. Parrott A C, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139: 261-268
37. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller H J, Hegerl U (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29: 1910-1917
38. Raine A (1989) Evoked potentials and psychopathy. Int J Psychophysiology 8: 1-16
39. Reneman L, Lavalaye J, Schmand B, de Wolff F A, van Den B W, den Heeten G J, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy'): preliminary findings. Arch Gen Psychiatry 58: 901-906
40. Ricaurte G A, Martello A L, Katz J L, Martello M B (1992) Lasting effects of MDMA on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261: 616-622
41. Ricaurte G A, McCann U D, Szabo Z, Scheffel U (2000) Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Toxicol Lett 112-113: 143-146
42. Rodgers J (2000) Cognitive performance amongst recreational users of 'ecstasy'. Psychopharmacology 151: 19-24
43. Scherg M (1991) Akustisch evozierte Potentiale-Grundlagen, Entstehungsmechanismen, Quellenmodell. Kohlhammer, Stuttgart
44. Scherg M, Vajsar J, Picton T W (1989) Source analysis of the late human auditory evoked potentials. J Cogn Neurosci 4: 336-355
45. Schmidt C J (1987) Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur J Pharmacol 136: 81-88
46. Stenberg G, Rosen I, Risberg J (1988) Personality and augmenting/reducing in visual and auditory potentials. Person Indiv Diff 9: 571-579
47. Takeuchi Y, Sano Y (1983) Immunohistochemical demonstration of serotonin nerve fibers in the neocortex of the monkey (Macaca fuscata). Anat Embryol 166: 155-168
48. Tuchtenhagen F, Daumann J, Norra C, Gobbelé R, Becker S, Pelz S, Sass H, Buchner H, Gouzoulis-Mayfrank E (2000) High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22: 608-617
49. Zakzanis K K, Young D A (2001) Memory impairment in abstinent MDMA ('ecstasy') users: a longitudinal investigation. Neurology 56: 966-969
50. Zuckerman M (1972) Drug usage as one manifestation of a 'sensationseeking' trait. In Keup W (ed.), Drug Abuse: Current Concepts and Research. Charles C Thomas Publisher, Springfield, IL
51. Zuckerman M (1990) The psychophysiology of sensation seeking. J Pers 58: 313-345
52. Zuckerman M, Simons R, Como P G (1988) Sensation seeking and stimulus intensity as modulators of cortical, cardiovascular and electrodermal response: A cross-modality study. Person Indiv Diff 9: 361-372